GenPro and Delaware’s Helen F. Graham Cancer Center Discover Novel EpiMarker

GenPro and Delaware’s Helen F. Graham Cancer Center Discover Novel EpiMarker

HemOnc Feb 2018 – GenPro & Delaware’s Helen F. Graham Cancer Center Discover novel EpiMarker with Potential to Predict Invasive vs Non-invasive DCIS Breast Cancer.Click Here for Article.